Purified activin B composition
Patent 5071834 Issued on December 10, 1991. Estimated Expiration Date: 
October 12, 2010. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
October 12, 2010. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesNovel human physiologically active polypeptide Patent #: 4879226 InventorsApplicationNo. 597293 filed on 10/12/1990US Classes:514/12, 25 or more peptide repeating units in known peptide chain structure514/8, Glycoprotein (carbohydrate containing)514/21, Produced by or extracted from animal tissue530/399Hormones, e.g., prolactin, thymosin, growth factors, etc.ExaminersPrimary: Schain, Howard E.Assistant: Koh, Choon P. Attorney, Agent or FirmForeign Patent References
International ClassesA61K 037/02A61K 037/43 AbstractA pharmaceutical composition and method are provided for erythropoietin therapy, such as treatment of an anemic disease, wherein an effective amount of activin with two betaB chains formulated in a pharmaceutically acceptable carrier is administered to a patient or animal in need of such therapy. Preferably the activin is human and the composition is administered parenterally.Other References
|
| ||||||||||||||
